← Eichor
Study identifier: NCT03237026 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Condition: Prostate Cancer  ·  Sponsor: National Taiwan University Hospital

PhaseN/A
Planned participants360
Who can joinMale, 30 Years to 100 Years
Healthy volunteersNo

About this study

The study aims to identify potential urine marker metabolites as predictive or prognostic markers for treatment outcomes in patients with prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Chung-Hsin Chen, MD PhD  ·  886-2-23123456  ·  mufasachen@gmail.com

Yeong-Shiau Pu, MD PhD  ·  886-2-23123456  ·  pu5249@ntuh.gov.tw

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan UniversityTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03237026